97 related articles for article (PubMed ID: 571044)
1. In vitro induction of lymphoblasts and cytotoxic lymphocytes with prostate tumor cells.
Frost P; Rose NR
Natl Cancer Inst Monogr; 1978 Dec; (49):169-72. PubMed ID: 571044
[No Abstract] [Full Text] [Related]
2. Antigenic properties of a cell line from human prostate carcinoma (EB 33).
Ackermann R; Okabe T; Schroeder FH
Natl Cancer Inst Monogr; 1978 Dec; (49):47-9. PubMed ID: 86166
[TBL] [Abstract][Full Text] [Related]
3. Human-mouse mixed lymphocyte cultures.
Boylston AW; Anderson RL
Immunology; 1978 Sep; 35(3):455-61. PubMed ID: 151664
[TBL] [Abstract][Full Text] [Related]
4. Immunologic studies of prostatic cancer using the R3327 rat model.
Lubaroff DM; Reynolds CW; Culp DA
Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
7. Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts.
Sharma B; Brunda MJ; Minden P
J Natl Cancer Inst; 1979 Aug; 63(2):341-6. PubMed ID: 222929
[No Abstract] [Full Text] [Related]
8. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
Lopez DM; Voigt W
Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
[TBL] [Abstract][Full Text] [Related]
9. In vitro immunization to cultured human tumor cells.
Sharma B; Terasaki PI
Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
[No Abstract] [Full Text] [Related]
10. Recognition and destruction of target cells by tumoricidal macrophages.
Fidler IJ
Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
[No Abstract] [Full Text] [Related]
11. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler IJ; Bucana C
Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
[TBL] [Abstract][Full Text] [Related]
13. Rat prostate carcinoma 11095-A: profile of organ- and tumor-specific antigens.
Lande IJ; Feldbush TL; Lubaroff DM; Bonney WW
Natl Cancer Inst Monogr; 1978 Dec; (49):283-7. PubMed ID: 86165
[TBL] [Abstract][Full Text] [Related]
14. Immunobiology of carcinoma of the prostate.
Catalona WJ
Invest Urol; 1980 Mar; 17(5):373-7. PubMed ID: 6987190
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.
Lum HE; Miller M; Davol PA; Grabert RC; Davis JB; Lum LG
Anticancer Res; 2005; 25(1A):43-52. PubMed ID: 15816517
[TBL] [Abstract][Full Text] [Related]
16. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
Frost P; Ng CP; Belldegrun A; Bonavida B
Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641
[TBL] [Abstract][Full Text] [Related]
17. Prostate antigen: a marker for human prostate epithelial cells.
Papsidero LD; Kuriyama M; Wang MC; Horoszewicz J; Leong SS; Valenzuela L; Murphy GP; Chu TM
J Natl Cancer Inst; 1981 Jan; 66(1):37-42. PubMed ID: 6935463
[TBL] [Abstract][Full Text] [Related]
18. Generation of cytotoxic lymphocytes by SV40-induced antigens.
Chang C; Chang R; Mora PT; Hu CP
J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
[TBL] [Abstract][Full Text] [Related]
19. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
[TBL] [Abstract][Full Text] [Related]
20. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
